SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001493152-18-010411
Filing Date
2018-07-25
Accepted
2018-07-25 06:15:24
Documents
2

Document Format Files

Seq Description Document Type Size
1 sc13da.htm SC 13D/A 65300
2 ex99-1.htm EX-99.1 6656
  Complete submission text file 0001493152-18-010411.txt   73331
Mailing Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121
Business Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Subject) CIK: 0001109196 (see all company filings)

IRS No.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-60385 | Film No.: 18967573
SIC: 2834 Pharmaceutical Preparations

Mailing Address 347 N. NEW RIVER DRIVE EAST #2904 FORT LAUDERDALE FL 33301
Business Address
Stetson John (Filed by) CIK: 0001553316 (see all company filings)

Type: SC 13D/A